Literature DB >> 21108616

Ocular manifestation of rheumatoid arthritis-different forms and frequency.

Gordana Zlatanović1, Dragan Veselinović, Sonja Cekić, Maja Zivković, Jasmina Dorđević-Jocić, Marko Zlatanović.   

Abstract

Rheumatoid arthritis (RA) is a systemic inflammatory disease associated with a number of extra-articular organ manifestations. Ocular manifestations involved with RA are keratoconjunctivitis sicca, episcleritis, scleritis , corneal changes, and retinal vasculitus. The etiopathogenesis of this autoimmune disorder is still unknown. Aim of our study was to present different ocular manifestations of RA and their frequency. We have examined 691 patient with the diagnoses of RA. All examined patients were in I or II stage of the disease according to criteria of The American College of Rheumatology. Ophthalmological exam obtained: visual acuity by Snellen sings, biomicroscopy of anterior segment, Schirmer test, tear break-up time (BUT), applanation tonometry and indirect ophthalmoscopy. In all patients with retinal vasculitis fotofundus and in indicated cases fluorescein angiography was preformed. The most common manifestation of ocular involvement was keratoconjunctivitis sicca. Episcleritis was diagnosed in 5.06% patients with RA, while scleritis was present in 2.06% of patients. Diffuse scleritis was present in one patient, while nodular was present in 13 patients. There were no patients with posterior or necrotizing scleritis among examined patients. Sclerosing keratitis was diagnosed in 11 female patients. It is characterized with peripheral thickening and opacification of the stroma adjacent to the site of inflammation. Posterior scleritis or scleromalacia of cornea was not present in our patients, because all of them were in I or II stage of disease. Retinal vasculitis was present in three patients, two male and one female patient (0.45%). Ocular manifestation was present in 27.2% of patients. Women were more affected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108616      PMCID: PMC5489043          DOI: 10.17305/bjbms.2010.2680

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  24 in total

1.  The impact of Rituximab therapy on the chromosomes of patients with Rheumatoid arthritis.

Authors:  Sekib Sokolović; Sida Kasumagić; Mirela Mackić-Durović; Izeta Aganović-Musinović
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  Scleritis.

Authors:  Chang-Pin Lin; Min-Hsiu Shih; Chuan-Yi Su
Journal:  Surv Ophthalmol       Date:  2006 May-Jun       Impact factor: 6.048

3.  Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis.

Authors:  K N Hakin; J Ham; S L Lightman
Journal:  Br J Ophthalmol       Date:  1991-06       Impact factor: 4.638

4.  [Systemic rheumatoid arthritis].

Authors:  V Lilleby; J T Gran
Journal:  Tidsskr Nor Laegeforen       Date:  1997-11-30

5.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

6.  Bacteriologic profile of the conjunctiva in the patients with dry eye.

Authors:  Yuichi Hori; Naoyuki Maeda; Masako Sakamoto; Shizuka Koh; Tomoyuki Inoue; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

7.  Rheumatoid scleritis.

Authors:  C C Barr; H Davis; W W Culbertson
Journal:  Ophthalmology       Date:  1981-12       Impact factor: 12.079

8.  Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.

Authors:  Lucia Sobrin; William Christen; C Stephen Foster
Journal:  Ophthalmology       Date:  2008-01-25       Impact factor: 12.079

9.  Infliximab therapy for the treatment of refractory ocular inflammatory disease.

Authors:  Lucia Sobrin; Eva C Kim; William Christen; Thekla Papadaki; Erik Letko; C Stephen Foster
Journal:  Arch Ophthalmol       Date:  2007-07

10.  Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.

Authors:  Eiki Goto; Yukihiro Matsumoto; Mizuka Kamoi; Koji Endo; Reiko Ishida; Murat Dogru; Minako Kaido; Takashi Kojima; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2007-05-23       Impact factor: 5.258

View more
  27 in total

1.  Evaluation of retrobulbar blood flow and choroidal thickness in patients with rheumatoid arthritis.

Authors:  Ali Kal; Enes Duman; Almila Sarıgül Sezenöz; Mahmut Oğuz Ulusoy; Öznur Kal
Journal:  Int Ophthalmol       Date:  2017-07-20       Impact factor: 2.031

2.  Alterations in biomechanical properties of the cornea among patients with polycystic kidney disease.

Authors:  Kubra Serefoglu Cabuk; Bennur Esen; Kursat Atalay; Ahmet Kirgiz; Rukiye Aydin
Journal:  Int Ophthalmol       Date:  2017-06-29       Impact factor: 2.031

Review 3.  Cogan's syndrome and other ocular vasculitides.

Authors:  Gabriela M Espinoza; Angela Prost
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 4.  Orbital Vasculitides-Differential Diagnosis.

Authors:  Gabriela M Espinoza; Jessica L Liu
Journal:  Curr Rheumatol Rep       Date:  2019-09-05       Impact factor: 4.592

5.  [Extra-articular manifestations of rheumatoid arthritis].

Authors:  C Baerwald; C Kneitz; M Bach; M Licht
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

6.  Color Doppler imaging of ocular hemodynamic changes in patients with rheumatoid arthritis unrelated to disease activity.

Authors:  Ozlem Unal; Mehmet Erol Can; Aysenur Ozcan; Meltem Ece Ozcan; Sukran Erten; Nurullah Cagil
Journal:  Rheumatol Int       Date:  2019-03-12       Impact factor: 2.631

7.  Radiographically Occult Manifestation of Rheumatoid Arthritis in a Patient With Prolonged Clinical and Laboratory Evidence of Rampant Disease: A Case Report.

Authors:  Yuri Korvatko; William C Bogar
Journal:  J Chiropr Med       Date:  2020-07-26

Review 8.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 9.  Impact of Climate Change on Eye Diseases and Associated Economical Costs.

Authors:  Lucía Echevarría-Lucas; José Mᵃ Senciales-González; María Eloísa Medialdea-Hurtado; Jesús Rodrigo-Comino
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

10.  Relationships between activated dendritic cells and dry eye symptoms and signs.

Authors:  Harry Levine; Jodi Hwang; Harrison Dermer; Divy Mehra; William Feuer; Anat Galor
Journal:  Ocul Surf       Date:  2021-06-06       Impact factor: 6.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.